CPT 78608 PET Brain Imaging Reimbursement

CPT code 78608 denotes a PET (positron emission tomography) study of the brain that measures metabolic processes such as oxygen, glucose, or drug metabolism to evaluate cerebral function. PET brain imaging plays a central role in neurologic diagnosis, staging of certain neurologic conditions, and treatment planning, making it a high-impact diagnostic code in national imaging practice and payment policy discussions. Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will find an overview of clinical context for PET brain imaging, typical sites of service, and commonly billed service lines. The publication summarizes payer coverage patterns and benchmark metrics where available, highlights relevant billing considerations, and outlines typical modifiers associated with advanced imaging claims. It also explains how CPT code 78608 fits within diagnostic nuclear medicine workflows and what to expect in terms of clinical indications and utilization drivers. Data not available in the input is noted where specific payer rates, ICD-10 pairings, or taxonomy mappings would normally appear.

Billing Code Overview

CPT code 78608 describes a positron emission tomography (PET) procedure focused on evaluating brain function and metabolism. The test assesses metabolic activity such as oxygen, glucose, or drug metabolism to provide functional imaging of the brain.

Service type: Diagnostic nuclear medicine imaging

Typical site of service: Hospital outpatient imaging center or freestanding nuclear medicine/PET imaging facility

Clinical Context

A 68-year-old patient with progressive cognitive decline and suspected Alzheimer disease is referred by a neurologist for a brain PET scan to evaluate regional cerebral glucose metabolism. The patient presents to an outpatient nuclear medicine clinic after pre-authorization and medication review. The usual workflow includes arrival and registration, verification of indications and prior imaging, IV placement for radiotracer administration, tracer uptake period (typically 30–60 minutes), image acquisition on a PET scanner, image reconstruction and attenuation correction (often using an integrated CT), and interpretation by a board-certified nuclear medicine physician or neuroradiologist. The study report documents radiotracer type, injected activity, patient preparation (fasting, medication adjustments), technical factors, qualitative and quantitative findings, and an impression that correlates with clinical referral.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when billing only the physician interpretation separate from technical component.
`TC`	Technical component	Use when billing only the technical component (scanner, technologist, radiopharmaceutical).

Taxonomy Code	Specialty	Notes
`208M00000X`	Nuclear Medicine Physician	Interprets PET studies and oversees radiopharmaceutical protocols.
`2084P0800X`	Neuroradiology	Subspecialists who interpret brain PET for neurodegenerative and oncologic indications.
`2085R0201X`	Diagnostic Radiology	Radiologists who perform and interpret PET/CT in many facilities.
`174400000X`	Radiologic Technologist	Performs PET acquisitions and radiotracer administration under supervision.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`G30.9`	Alzheimer disease, unspecified	Common indication to assess regional hypometabolism patterns consistent with Alzheimer disease.
`G40.901`	Epilepsy, unspecified, not intractable, with status epilepticus	Interictal PET can localize epileptogenic foci in surgical candidates.
`R41.3`	Other amnesia	PET can help evaluate metabolic patterns in patients with memory impairment.
`F02.80`	Dementia in other diseases classified elsewhere without behavioral disturbance	Used when dementia is secondary to other neurologic conditions and metabolism assessment aids diagnosis.
`G31.84`	Mild cognitive impairment, so stated	PET may be used in select cases to help characterize neurodegenerative vs. non-neurodegenerative causes.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`78815`	Positron emission tomography (PET) imaging, tumor evaluation; whole body, single study, with or without concurrently performed limited, localized PET imaging	May be used for oncologic PET studies when whole-body imaging is required; complements brain PET when systemic disease evaluation is needed.
`78816`	Positron emission tomography (PET) imaging, tumor evaluation; limited, localized PET study, single area	Used for focused PET imaging of a specific region and may be billed when brain-only tumor assessment is performed.
`70450`	CT head/brain without contrast	Often performed as the CT component for attenuation correction or as part of a PET/CT protocol.
`78608`	Positron emission tomography (PET) imaging, brain, metabolic evaluation	Primary procedure for regional brain metabolic assessment; used for dementia, epilepsy, and metabolic brain disorders.
`96413`	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug	Included as an example of infusion codes sometimes used for intravenous radiopharmaceutical administration documentation when facility-specific billing applies (verify payer policies).

OpenPayer

Summary & Overview

CPT 78608: PET Brain Metabolic Imaging